Merrill Lynch Women’s Health & Reproductive Rights

Investment Type: Public Equity
Year: 2015, 2016, 2017
Amount: $2.5 million
Organization Type: For-profit

Women’s Health & Reproductive Rights (WHRR) is an investment portfolio that utilizes investment criteria to identify companies that make a meaningful contribution to women’s reproductive health. This includes companies that support family planning and reproductive health through products, services and human resources policies.

Why we invest:

WHRR is a portfolio designed specifically by our wealth advisors at Merrill Lynch, Pierce, Fenner & Smith Inc. (Merrill Lynch) to address our desire for a targeted impact investment portfolio with a focus on reproductive health. Our advisors at Merrill Lynch researched and selected approximately 30 public companies that align with Tara Health’s mission.

The Foust/Meeker Team at Merrill Lynch includes Mary K. Foust, Senior Vice President of Wealth Management, and Alena M. Meeker, First Vice President of Wealth Management. Read more about the Foust/Meeker team here.

< Return to Portfolio